Welcome
Unlike traditional hospital and large clinical settings, Minnesota Oncology is a specialized medical group dedicated solely to the diagnosis and treatment of various cancers as well as many blood disorders – All in a non-threatening, neighborhood environment.
Latest Cancer News
Oncotype DX® Predicts Recurrence in Patients with DCIS
(06-18-2013)
The Oncotype DX® DCIS Score predicts the 10-year risk of local recurrence, defined as recurrence of DCIS or invasive breast cancer in the same breast, and can help guide radiation treatment decision-making... Continue Reading
FDA Approves Xofigo for Advanced Prostate Cancer (06-17-2013)
The U.S. Food and Drug Administration (FDA) has approved Xofigo® (radium Ra 223 dichloride) to treat men with metastatic, hormone-refractory prostate cancer that has spread to bones but not to other organs.... Continue Reading
Genomic Testing May Reduce Medical Costs for Colon Cancer (06-14-2013)
Use of the Oncotype DX® colon cancer test to guide treatment decisions may reduce medical costs and improve patient well-being. These results were presented at the 2013 Annual Meeting of the American... Continue Reading
The Oncotype DX® DCIS Score predicts the 10-year risk of local recurrence, defined as recurrence of DCIS or invasive breast cancer in the same breast, and can help guide radiation treatment decision-making... Continue Reading
FDA Approves Xofigo for Advanced Prostate Cancer (06-17-2013)
The U.S. Food and Drug Administration (FDA) has approved Xofigo® (radium Ra 223 dichloride) to treat men with metastatic, hormone-refractory prostate cancer that has spread to bones but not to other organs.... Continue Reading
Genomic Testing May Reduce Medical Costs for Colon Cancer (06-14-2013)
Use of the Oncotype DX® colon cancer test to guide treatment decisions may reduce medical costs and improve patient well-being. These results were presented at the 2013 Annual Meeting of the American... Continue Reading
More Cancer News
Types of Cancer
More Cancer Types
Current Resources
